Matthew P. Wagoner

1.1k total citations
21 papers, 756 citations indexed

About

Matthew P. Wagoner is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Matthew P. Wagoner has authored 21 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in Matthew P. Wagoner's work include Drug Transport and Resistance Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Matthew P. Wagoner is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Matthew P. Wagoner collaborates with scholars based in United States, Japan and United Kingdom. Matthew P. Wagoner's co-authors include Richard A. Anderson, Kun Ling, Yue Sun, Avtar Roopra, Kenneth J. O’Riordan, Susan Osting, Corinna Bürger, Andreas Friedl, Barry Schoenike and Kearney T. W. Gunsalus and has published in prestigious journals such as The Journal of Cell Biology, Blood and PLoS ONE.

In The Last Decade

Matthew P. Wagoner

20 papers receiving 736 citations

Peers

Matthew P. Wagoner
Saeed Akhtar Saudi Arabia
Lynn Rowley Australia
Swathi Ayloo United States
Takayuki Nagasaki United States
Shigeo Tamiya United States
Buu P. Tu United States
Cynthia Gallant United States
Matthew P. Wagoner
Citations per year, relative to Matthew P. Wagoner Matthew P. Wagoner (= 1×) peers Hucheng Zhao

Countries citing papers authored by Matthew P. Wagoner

Since Specialization
Citations

This map shows the geographic impact of Matthew P. Wagoner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Wagoner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Wagoner more than expected).

Fields of papers citing papers by Matthew P. Wagoner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew P. Wagoner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Wagoner. The network helps show where Matthew P. Wagoner may publish in the future.

Co-authorship network of co-authors of Matthew P. Wagoner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Wagoner. A scholar is included among the top collaborators of Matthew P. Wagoner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Wagoner. Matthew P. Wagoner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shinozawa, Tadahiro, Kazumasa Miyamoto, K. Scott Baker, et al.. (2025). TAK-994 mechanistic investigation into drug-induced liver injury. Toxicological Sciences. 204(2). 143–153. 2 indexed citations
2.
McDonald, Jay R., Matthew P. Wagoner, Faraz Shaikh, et al.. (2024). Mental and Physical Health-Related Quality of Life Following Military Polytrauma. Military Medicine. 189(11-12). 2550–2561.
3.
Bajaj, Piyush, Git Chung, Tomoya Yukawa, et al.. (2020). Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity. Toxicology. 442. 152535–152535. 22 indexed citations
4.
Yamanaka, Kazunori, et al.. (2020). Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes. Journal of Pharmacological and Toxicological Methods. 105. 106893–106893. 7 indexed citations
5.
Uchiyama, Noriko, Tomoya Yukawa, Yvonne P. Dragan, Matthew P. Wagoner, & Russell Naven. (2020). New phenotypic cytotoxicity assay for ROS-inducing compounds using rat renal epithelial cells. Toxicology Letters. 331. 227–234. 1 indexed citations
6.
Korver, Wouter, Mary Carsillo, Neeraja Idamakanti, et al.. (2019). A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 370(2). 182–196. 22 indexed citations
7.
Matsui, Toshikatsu, et al.. (2019). Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicology and Applied Pharmacology. 383. 114761–114761. 13 indexed citations
8.
Fedyk, Eric R., Neeraja Idamakanti, Jia Chen, et al.. (2019). The Binding of CD38 Therapeutics to Red Blood Cells and Platelets Subverts Depletion of Target Cells. Blood. 134(Supplement_1). 3136–3136. 1 indexed citations
9.
Peters, Matthew F., T. Landry, Carmen Pin, et al.. (2018). Human 3D Gastrointestinal Microtissue Barrier Function As a Predictor of Drug-Induced Diarrhea. Toxicological Sciences. 168(1). 3–17. 42 indexed citations
10.
Wagoner, Matthew P., Yi Yang, J. Eric McDuffie, et al.. (2017). Evaluation of Temporal Changes in Urine-based Metabolomic and Kidney Injury Markers to Detect Compound Induced Acute Kidney Tubular Toxicity in Beagle Dogs. Current Topics in Medicinal Chemistry. 17(24). 2767–2780. 26 indexed citations
11.
Tseng, Hubert, Jacob A. Gage, William L. Haisler, et al.. (2016). A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting. Scientific Reports. 6(1). 30640–30640. 52 indexed citations
12.
McDuffie, J. Eric, Jingjin Gao, David La, et al.. (2013). Novel genomic biomarkers for acute gentamicin nephrotoxicity in dog. 3(3). 125–133. 11 indexed citations
13.
Gunsalus, Kearney T. W., Matthew P. Wagoner, Kassondra Meyer, et al.. (2012). Induction of the RNA Regulator LIN28A Is Required for the Growth and Pathogenesis of RESTless Breast Tumors. Cancer Research. 72(13). 3207–3216. 13 indexed citations
14.
Wagoner, Matthew P. & Avtar Roopra. (2012). A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease. BMC Genomics. 13(1). 686–686. 15 indexed citations
15.
O’Riordan, Kenneth J., et al.. (2010). Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK. PLoS ONE. 5(2). e8996–e8996. 155 indexed citations
16.
Wagoner, Matthew P., Kearney T. W. Gunsalus, Barry Schoenike, et al.. (2010). The Transcription Factor REST Is Lost in Aggressive Breast Cancer. PLoS Genetics. 6(6). e1000979–e1000979. 75 indexed citations
17.
Wagoner, Matthew P., Kun Ling, & Richard A. Anderson. (2008). Tracking the Transport of E-Cadherin to and From the Plasma Membrane. Methods in molecular biology. 267–278. 3 indexed citations
18.
Mellman, David L., et al.. (2007). A Conspicuous Connection: Structure Defines Function for the Phosphatidylinositol-Phosphate Kinase Family. Critical Reviews in Biochemistry and Molecular Biology. 42(1). 15–39. 82 indexed citations
19.
Sun, Yue, Kun Ling, Matthew P. Wagoner, & Richard A. Anderson. (2007). Type Iγ phosphatidylinositol phosphate kinase is required for EGF-stimulated directional cell migration. The Journal of Cell Biology. 178(2). 297–308. 69 indexed citations
20.
Ling, Kun, et al.. (2006). Movin' on up: the role of PtdIns(4,5)P2 in cell migration. Trends in Cell Biology. 16(6). 276–284. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026